The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
With an estimated population of 8.3 million, Sierra Leone has no existing pharmaceutical manufacturing company at present. The recent COVID-19 pandemic brought to the limelight the fragility and weakness of the Sierra Leonean pharmaceutical industry as it resulted in severe drug shortages and medici...
Saved in:
Main Authors: | Eugene Conteh (Author), Melody Okereke (Author), Foday Umaro Turay (Author), Alhaji Sununu Bah (Author), Abdulwasiu Muhsinah (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
by: Melody Okereke, et al.
Published: (2022) -
Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
by: Yakuba M Bah, et al.
Published: (2020) -
Routine vitamin A supplementation and other high impact interventions in Sierra Leone
by: Aminata S. Koroma, et al.
Published: (2020) -
Designing a leadership and management training curriculum for undergraduate health professions students: Lessons from the University of Sierra Leone
by: Oliver Johnson, et al.
Published: (2023) -
Religious leaders' nuanced views on birth spacing and contraceptives in Sierra Leone - qualitative insights
by: Regina Mamidy Yillah, et al.
Published: (2024)